BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31655110)

  • 1. Strategies to achieve immune tolerance in allogeneic solid organ transplantation.
    Zeng S; Xiao Z; Wang Q; Guo Y; He Y; Zhu Q; Zou Y
    Transpl Immunol; 2020 Feb; 58():101250. PubMed ID: 31655110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhuman primate models of transplant tolerance: closer to the holy grail.
    Kitchens WH; Adams AB
    Curr Opin Organ Transplant; 2016 Feb; 21(1):59-65. PubMed ID: 26709576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts.
    Exner BG; Acholonu IN; Bergheim M; Mueller YM; Ildstad ST
    Acta Haematol; 1999; 101(2):78-81. PubMed ID: 10202237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells: first steps of clinical application in solid organ transplantation.
    van der Net JB; Bushell A; Wood KJ; Harden PN
    Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming immunological barriers in regenerative medicine.
    Zakrzewski JL; van den Brink MR; Hubbell JA
    Nat Biotechnol; 2014 Aug; 32(8):786-94. PubMed ID: 25093888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune tolerance and transplantation.
    Alpdogan O; van den Brink MR
    Semin Oncol; 2012 Dec; 39(6):629-42. PubMed ID: 23206840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells as a therapeutic tool to induce solid-organ transplant tolerance: current clinical experiences.
    Nikoueinejad H; Sharif MR; Amirzargar A; Mirshafiey A; Einollahi B
    Exp Clin Transplant; 2013 Oct; 11(5):379-87. PubMed ID: 23902519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
    Bertaina A; Roncarolo MG
    Front Immunol; 2019; 10():1342. PubMed ID: 31354695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of transplantation tolerance via regulatory T cells.
    Battaglia M; Roncarolo MG
    Inflamm Allergy Drug Targets; 2006 Sep; 5(3):157-65. PubMed ID: 16918479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic Donor Cells in Transplantation.
    Husain I; Luo X
    Front Immunol; 2021; 12():626840. PubMed ID: 33717145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of allograft tolerance in intestinal transplantation.
    Meier D; Rumbo M; Gondolesi GE
    Int Rev Immunol; 2014; 33(3):245-60. PubMed ID: 24328710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation.
    Fändrich F
    Curr Opin Organ Transplant; 2010 Dec; 15(6):703-8. PubMed ID: 20930635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tolerance to alloantigen.
    Witzke O; Barbara JA; Wood KJ
    Rev Immunogenet; 1999; 1(3):374-86. PubMed ID: 11256428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Costimulatory Blockade to Induce Immune Tolerance in Liver Transplantation.
    Ding M; He Y; Zhang S; Guo W
    Front Immunol; 2021; 12():537079. PubMed ID: 33732228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical tolerance in allogeneic hematopoietic stem cell transplantation.
    Roncarolo MG; Gregori S; Lucarelli B; Ciceri F; Bacchetta R
    Immunol Rev; 2011 May; 241(1):145-63. PubMed ID: 21488896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation.
    Pilat N; Hock K; Wekerle T
    Curr Opin Organ Transplant; 2012 Feb; 17(1):63-70. PubMed ID: 22186093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation.
    Nakamura T; Ushigome H
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.